1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with lead in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chang, W; Chen, J; Li, F; Li, J; Li, X; Ye, F; Yuan, J | 1 |
Ayyalasomayajula, N; Bandaru, LJM; Challa, S; Dixit, PK; Murumulla, L | 1 |
2 other study(ies) available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and lead
Article | Year |
---|---|
Cyclosporin A protects against Lead neurotoxicity through inhibiting mitochondrial permeability transition pore opening in nerve cells.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenosine Triphosphate; Animals; Apoptosis Inducing Factor; Cell Line, Transformed; Cyclosporins; Cytochromes c; Humans; L-Lactate Dehydrogenase; Lead; Membrane Potential, Mitochondrial; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Neuroblastoma; Neurons; Neuroprotective Agents; Neurotoxins; PC12 Cells; Rats; Reactive Oxygen Species | 2016 |
Defective mitophagy and induction of apoptosis by the depleted levels of PINK1 and Parkin in Pb and β-amyloid peptide induced toxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Alzheimer Disease; Amyloid beta-Peptides; Apoptosis; Humans; Lead; Mitophagy; Neuroblastoma; Protein Kinases; Reactive Oxygen Species; Ubiquitin-Protein Ligases | 2022 |